Putuo Intelligence Medicine Completes Nearly Billion Yuan Angel Round Financing

Recently, PUNOAI announced the completion of nearly tens of millions of yuan in angel round financing. This round of financing is led by Huagai Capital and Boyuan Capital, with follow-up investment from Mint Angel Fund, among others. This round of financing will be mainly used for: accelerating the preclinical candidate molecule development and IND application of the STAT6 project; comprehensively promoting the IND application of the degrader core pipeline PPI-101; accelerating the rapid optimization iteration of the AI drug research and development platform based on protein-protein interactions.